IP Library Granted Patent US 12,419,744
Granted Patent B2
US 12,419,744 · App. 15/399,638 · Granted Sep 23, 2025

Systems and methods for transcatheter aortic valve treatment

Inventors: Michi E. Garrison (Sunnyvale, CA); Tony M. Chou (Sunnyvale, CA); Gregory M. Hyde (Sunnyvale, CA)
Assignee: BOSTON SCIENTIFIC SCIMED, INC.
A61F2/2436A61B17/0401A61B17/12122A61F2/013A61F2/2427A61B2017/0409A61F2002/018A61F2220/0008A61F2220/0075A61F2230/0006A61F2230/0008A61F2230/0067
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,419,744
App. No.
15/399,638
Granted
Sep 23, 2025
Kind
B2
Abstract

Devices and methods are configured to allow transcervical or subclavian access via the common carotid artery to the native aortic valve, and implantation of a prosthetic aortic valve into the heart. The devices and methods also provide means for embolic protection during such an endovascular aortic valve implantation procedure.

Claims (37)

1. A system for treating an aortic valve, comprising:

an arterial access sheath configured to be inserted into an access point in a common carotid artery through a penetration in a neck of a patient, the arterial access sheath having an internal lumen;

wherein the arterial access sheath has a first lumen configured to receive a valve delivery system, the valve delivery system configured to deliver a prosthetic valve into a heart or aorta through the arterial access sheath, the first lumen having a first opening at a proximal end of the arterial access sheath and a second opening at a distal most end of the arterial access sheath;

wherein the arterial access sheath further has a first Y-arm located at a proximal region of the arterial access sheath, the first Y-arm splitting into a flow shunt and into the first opening at the proximal end of the arterial access sheath such that the Y-arm communicates with the flow shunt that is configured to reintroduce blood flow into the carotid artery at a location upstream from the access point into the carotid artery, the flow shunt connected to the first Y-arm of the arterial access sheath at a first end of the shunt and such that the first Y-arm also communicates with the first opening at the proximal end of the arterial access sheath;

a second Y-arm connected to the flow shunt at a second end of the flow shunt wherein the second Y-arm fluidly connects the flow shunt to a second, parallel lumen of the arterial access sheath, the parallel lumen being positioned parallel with at least a portion of the internal lumen of the arterial access sheath such that the arterial access sheath contains two lumens that are simultaneously open, and wherein the second, parallel lumen forms a third opening of the arterial access sheath, the third opening being positioned along the arterial access sheath proximal of the second opening and wherein blood flows out of the third opening solely from the second, parallel lumen, and wherein the internal lumen of the arterial access sheath has a uniform diameter distal of the third opening, and wherein the parallel lumen and the first lumen concurrently provide fixed flow paths and are separated by a fixed wall;

a guidewire sized and shaped to be inserted through the arterial access sheath and across a native aortic valve;

a filter configured to be deployed in an artery via the penetration, the filter being sized and shaped to be deployed within the aortic arch so that all the head and neck vessels are protected by the filter from embolic debris during a valve implantation procedure, wherein the filter has a substantially conical shape when positioned in the aortic arch such that a widened portion of the filter traverses an entire diameter of an ascending portion of the aorta when deployed in the aorta, wherein the filter is positioned substantially on one side of the sheath when deployed; and

a prosthetic valve configured to be inserted through the arterial access sheath and percutaneously deployed at or near the position of the native aortic valve.

2. The system of claim 1 , wherein the filter is attached to the sheath.

3. The system of claim 1 , wherein the filter further has a narrowed portion such that the narrowed portion of the filter extends into a descending portion of the aorta when deployed in the aorta.

4. The system of claim 3 , wherein the widened portion of the filter forms an open mouth that is open toward the ascending portion of aorta.

5. The system of claim 4 , wherein the narrowed portion of the filter forms an enclosed portion of the filter.

6. A system for treating an aortic valve, comprising:

an arterial access sheath configured to be inserted into an access point in a common carotid artery through a penetration in a neck of a patient, the arterial access sheath having a proximal end, a proximal opening at the proximal end, a distal end, a distal opening at the distal end;

wherein a first lumen is defined in the arterial access sheath that extends from the proximal opening of the arterial access sheath to the distal opening of the arterial access sheath;

wherein the first lumen configured to receive a valve delivery system, the valve delivery system being configured to deliver a prosthetic valve into a heart or aorta through the arterial access sheath;

a hub coupled to the proximal end of the arterial access sheath, the hub including a first Y-arm in fluid communication with the first lumen;

wherein the hub includes a second Y-arm in fluid communication with a second lumen defined in the arterial access sheath, the second lumen extending to a distal port disposed proximally of the distal end of the arterial access sheath;

wherein the arterial access sheath includes a fixed internal wall that separates the first lumen from the second lumen so that the first lumen and the second lumen are simultaneously open during use of the arterial access sheath; and

a shunt coupled to the first Y-arm and to the second Y-arm, the shunt being configured to reintroduce blood flow into the carotid artery at a location upstream from the access point into the carotid artery.

7. The system of claim 6 , further comprising a guidewire sized and shaped to be inserted through the arterial access sheath and across a native aortic valve.

8. The system of claim 6 , further comprising a filter configured to be deployed in an artery via the penetration, the filter being sized and shaped to be deployed within the aortic arch so that all the head and neck vessels are protected by the filter from embolic debris during a valve implantation procedure.

9. The system of claim 8 , wherein the filter has a substantially conical shape when positioned in the aortic arch such that a widened portion of the filter traverses an entire diameter of an ascending portion of the aorta when deployed in the aorta.

10. The system of claim 8 , wherein the filter is positioned substantially on one side of the sheath when deployed.

11. The system of claim 8 , wherein the filter is attached to the sheath.

12. The system of claim 8 , wherein the filter further has a narrowed portion such that the narrowed portion of the filter extends into a descending portion of the aorta when deployed in the aorta.

13. The system of claim 12 , wherein the widened portion of the filter forms an open mouth that is open toward the ascending portion of aorta.

14. The system of claim 13 , wherein the narrowed portion of the filter forms an enclosed portion of the filter.

15. The system of claim 6 , further comprising a prosthetic valve configured to be inserted through the arterial access sheath and percutaneously deployed at or near the position of the native aortic valve.

16. A system for treating an aortic valve, comprising:

an arterial access sheath configured to be inserted into an access point in a common carotid artery through a penetration in a neck of a patient, the arterial access sheath having a proximal end, a proximal opening at the proximal end, a distal end, a distal opening at the distal end;

wherein a first lumen is defined in the arterial access sheath that extends from the proximal opening of the arterial access sheath to the distal opening of the arterial access sheath;

wherein the first lumen configured to receive a valve delivery system, the valve delivery system being configured to deliver a prosthetic valve into a heart or aorta through the arterial access sheath;

a hub coupled to the proximal end of the arterial access sheath, the hub including a first Y-arm in fluid communication with the first lumen;

wherein the hub includes a second Y-arm in fluid communication with a second lumen defined in the arterial access sheath, the second lumen extending to a distal port disposed proximally of the distal end of the arterial access sheath;

wherein the arterial access sheath includes an immovable internal wall that separates the first lumen from the second lumen so that the first lumen and the second lumen are simultaneously open during use of the arterial access sheath; and

a shunt coupled to the first Y-arm and to the second Y-arm, the shunt being configured to reintroduce blood flow into the carotid artery at a location upstream from the access point into the carotid artery.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 28, 2025
From: SILK ROAD MEDICAL, INC.
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 070671/0426 →
RELEASE OF SECURITY INTEREST Recorded Sep 17, 2024
From: OXFORD FINANCE, LLC
To: SILK ROAD MEDICAL, INC.
Reel/Frame 068979/0196 →
SECURITY INTEREST Recorded Jul 11, 2023
From: SILK ROAD MEDICAL, INC.
To: OXFORD FINANCE LLC
Reel/Frame 064252/0197 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 10, 2017
From: GARRISON, MICHI E.; CHOU, TONY M.; HYDE, GREGORY M.
To: SILK ROAD MEDICAL, INC.
Reel/Frame 041536/0556 →
Continuity (4)
Continuation 14042520 · Sep 30, 2013
Continuation 13034513 · Feb 24, 2011
Provisional Application 61308606 · Feb 26, 2010
Related Publication 20170209260A1 · Jul 27, 2017
References Cited (179)
US 5947995A · Samuels · 1999 [cited by examiner]
US 6071271A · Baker et al. · 2000 [cited by applicant]
US 6165162A · Safar et al. · 2000 [cited by applicant]
US 6413235B1 · Parodi · 2002 [cited by applicant]
US 6423032B2 · Parodi · 2002 [cited by applicant]
US 6454799B1 · Schreck · 2002 [cited by applicant]
US 6595953B1 · Coppi et al. · 2003 [cited by applicant]
US 6837881B1 · Barbut · 2005 [cited by applicant]
US 6866650B2 · Stevens et al. · 2005 [cited by applicant]
US 7083594B2 · Coppi · 2006 [cited by applicant]
US 7749245B2 · Cohn et al. · 2010 [cited by applicant]
US 7803168B2 · Gifford et al. · 2010 [cited by applicant]
US 8182530B2 · Huber · 2012 [cited by applicant]
US 8287583B2 · LaDuca et al. · 2012 [cited by applicant]
US 8545552B2 · Garrison et al. · 2013 [cited by applicant]
US 20010032004A1 · Werneth · 2001 [cited by applicant]
US 20010044598A1 · Parodi · 2001 [cited by applicant]
US 20020062134A1 · Barbut et al. · 2002 [cited by applicant]
US 20020123766A1 · Seguin et al. · 2002 [cited by applicant]
US 20030135257A1 · Taheri · 2003 [cited by applicant]
US 20030153943A1 · Michael et al. · 2003 [cited by applicant]
US 20030187475A1 · Tsugita et al. · 2003 [cited by applicant]
US 20050015112A1 · Cohn et al. · 2005 [cited by applicant]
US 20050085761A1 · Wang · 2005 [cited by examiner]
US 20050137686A1 · Salahieh · 2005 [cited by examiner]
US 20050137696A1 · Salahieh et al. · 2005 [cited by applicant]
US 20050148997A1 · Valley et al. · 2005 [cited by applicant]
US 20050154344A1 · Chang · 2005 [cited by examiner]
US 20050154349A1 · Renz et al. · 2005 [cited by applicant]
US 20060020327A1 · Lashinski et al. · 2006 [cited by applicant]
US 20060020334A1 · Lashinski et al. · 2006 [cited by applicant]
US 20060106338A1 · Chang · 2006 [cited by applicant]
US 20060155366A1 · LaDuca et al. · 2006 [cited by applicant]
US 20060276837A1 · Bergin et al. · 2006 [cited by applicant]
US 20070021774A1 · Hogendijk · 2007 [cited by examiner]
US 20080065145A1 · Carpenter · 2008 [cited by applicant]
US 20080125861A1 · Webler et al. · 2008 [cited by applicant]
US 20090018455A1 · Chang · 2009 [cited by applicant]
US 20090024072A1 · Criado et al. · 2009 [cited by applicant]
US 20090198172A1 · Garrison et al. · 2009 [cited by applicant]
US 20090254166A1 · Chou et al. · 2009 [cited by applicant]
US 20090326575A1 · Galdonik et al. · 2009 [cited by applicant]
US 20100004740A1 · Seguin · 2010 [cited by examiner]
US 20100042118A1 · Garrison et al. · 2010 [cited by applicant]
US 20100179585A1 · Carpenter · 2010 [cited by examiner]
US 20100185216A1 · Garrison et al. · 2010 [cited by applicant]
US 20100191169A1 · Chang · 2010 [cited by applicant]
US 20100191170A1 · Chang · 2010 [cited by applicant]
US 20100204684A1 · Garrison et al. · 2010 [cited by applicant]
US 20100217276A1 · Garrison et al. · 2010 [cited by applicant]
US 20100228269A1 · Garrison et al. · 2010 [cited by applicant]
US 20100280431A1 · Criado et al. · 2010 [cited by applicant]
US 20110004147A1 · Renati et al. · 2011 [cited by applicant]
US 20110034986A1 · Chou et al. · 2011 [cited by applicant]
US 20110082408A1 · Chang · 2011 [cited by applicant]
US 20110087147A1 · Garrison et al. · 2011 [cited by applicant]
US 20110125131A1 · Chang · 2011 [cited by applicant]
US 20110166496A1 · Criado et al. · 2011 [cited by applicant]
US 20110166497A1 · Criado et al. · 2011 [cited by applicant]
US 20110257577A1 · Lane et al. · 2011 [cited by applicant]
US 20130172852A1 · Chang · 2013 [cited by applicant]
US 20130197621A1 · Ryan et al. · 2013 [cited by applicant]
US 20140031682A1 · Renati et al. · 2014 [cited by applicant]
US 20140058414A1 · Garrison et al. · 2014 [cited by applicant]
US 20140371653A1 · Criado et al. · 2014 [cited by applicant]
US 20150025616A1 · Chang · 2015 [cited by applicant]
US 20150141760A1 · Chou et al. · 2015 [cited by applicant]
US 20150150562A1 · Chang · 2015 [cited by applicant]
US 20160128688A1 · Garrison et al. · 2016 [cited by applicant]
US 20160158044A1 · Chou et al. · 2016 [cited by applicant]
US 20160271315A1 · Chang · 2016 [cited by applicant]
US 20160271316A1 · Criado et al. · 2016 [cited by applicant]
US 20160279379A1 · Chang · 2016 [cited by applicant]
US 20170312491A1 · Ryan et al. · 2017 [cited by applicant]
US 20170354523A1 · Chou et al. · 2017 [cited by applicant]
US 20170361072A1 · Chou et al. · 2017 [cited by applicant]
US 20170368296A1 · Chang · 2017 [cited by applicant]
US 20180154063A1 · Criado et al. · 2018 [cited by applicant]
US 20180289884A1 · Criado et al. · 2018 [cited by applicant]
US 20190105439A1 · Criado et al. · 2019 [cited by applicant]
US 20190231962A1 · Criado et al. · 2019 [cited by applicant]
US 20190254680A1 · Chang · 2019 [cited by applicant]
US 20190262530A1 · Criado et al. · 2019 [cited by applicant]
US 20190269538A1 · Chou et al. · 2019 [cited by applicant]
US 20190388654A1 · Chou et al. · 2019 [cited by applicant]
US 20200015826A1 · Chang · 2020 [cited by applicant]
US 20200016321A1 · Criado et al. · 2020 [cited by applicant]
US 20200108221A1 · Chang · 2020 [cited by applicant]
US 20200170637A1 · Garrison et al. · 2020 [cited by applicant]
US 20200282127A1 · Garrison et al. · 2020 [cited by applicant]
US 20200297912A1 · Criado et al. · 2020 [cited by applicant]
US 20200390438A1 · Garrison et al. · 2020 [cited by applicant]
US 20200397446A1 · Chang · 2020 [cited by applicant]
U.S. Appl. No. 12/366,287, filed Feb. 5, 2009, US 2009-0254166. [cited by applicant]
U.S. Appl. No. 12/645,179, filed Dec. 22, 2009, US 2010-0217276. [cited by applicant]
U.S. Appl. No. 13/816,670, filed Feb. 12, 2013, US 2013-0197621. [cited by applicant]
U.S. Appl. No. 13/961,746, filed Aug. 7, 2013, US 2014-0046346. [cited by applicant]
U.S. Appl. No. 14/042,520, filed Sep. 30, 2013, US 2014-003125. [cited by applicant]
U.S. Appl. No. 14/078,149, filed Nov. 12, 2013, US 2014-0135661. [cited by applicant]
U.S. Appl. No. 14/221,917, filed Mar. 21, 2014, US 2014-0296868. [cited by applicant]
U.S. Appl. No. 14/475,346, filed Sep. 2, 2014, US 2014-0371653. [cited by applicant]
U.S. Appl. No. 14/508,354, filed Oct. 7, 2014, US 2015-0025616. [cited by applicant]
U.S. Appl. No. 14/710,400, filed May 12, 2015, US 2015-0327843. [cited by applicant]
U.S. Appl. No. 14/935,252, filed Nov. 6, 2015, US 2016-0128688. [cited by applicant]
U.S. Appl. No. 15/044,493, filed Feb. 16, 2016, US 2016-0158044. [cited by applicant]
U.S. Appl. No. 15/082,257, filed Mar. 28, 2016, US 2016-0279379. [cited by applicant]
U.S. Appl. No. 15/093,406, filed Apr. 7, 2016, US 2016-0296690. [cited by applicant]
U.S. Appl. No. 15/168,786, filed May 31, 2016, US 2016-0271315. [cited by applicant]
U.S. Appl. No. 15/168,809, filed May 31, 2016, US 2016-0271316. [cited by applicant]
U.S. Appl. No. 15/210,770, filed Jul. 14, 2016, US 2017-0043141. [cited by applicant]
PCT/US2015/030375, May 12, 2015, WO 2015/175537. [cited by applicant]
PCT/US2015/047717, Aug. 31, 2015, WO 2016/036660. [cited by applicant]
PCT/US2016/029701, Apr. 28, 2016, WO 2016/176409. [cited by applicant]
PCT/US2016/018898, Feb. 22, 2016, WO 2016/137875. [cited by applicant]
PCT/US2016/026483, Apr. 7, 2016, WO 2016/164606. [cited by applicant]
Henry et al. (1999) “Carotid stenting with cerebral protection: First clinical experience using the PercuSurge GuardWire System” J. Endovasc. Surg. 6:321-331. [cited by applicant]
U.S. Appl. No. 16/008,703, filed Jun. 14, 2018, US 2018-0289884. [cited by applicant]
U.S. Appl. No. 16/256,229, filed Jan. 24, 2019, US 2019-0254680. [cited by applicant]
U.S. Appl. No. 16/581,034, filed Sep. 24, 2019, US 2020-0015826. [cited by applicant]
U.S. Appl. No. 16/581,061, filed Sep. 24, 2019, US 2020-0016321. [cited by applicant]
PCT/US18/40264, Jun. 29, 2018, WO 2019/010077. [cited by applicant]
PCT/US18/57789, Oct. 26, 2018, WO 2019/089385. [cited by applicant]
U.S. Appl. No. 15/141,060, filed Apr. 28, 2016, US 2016-0317288. [cited by applicant]
U.S. Appl. No. 15/641,966, filed Jul. 5, 2017, US 2017-0296798. [cited by applicant]
U.S. Appl. No. 15/901,502, filed Feb. 21, 2018, US 2018-0235789. [cited by applicant]
U.S. Appl. No. 16/056,208, filed Aug. 6, 2018, US 2019-0175885. [cited by applicant]
U.S. Appl. No. 16/148,849, filed Oct. 1, 2018, US 2019-0269538. [cited by applicant]
U.S. Appl. No. 16/171,784, filed Oct. 26, 2018, US 2019-0125512. [cited by applicant]
U.S. Appl. No. 16/177,716, filed Nov. 1, 2018, US 2019-0150916. [cited by applicant]
U.S. Appl. No. 16/250,825, filed Jan. 17, 2019, US 2019-0350568. [cited by applicant]
U.S. Appl. No. 16/281,311, filed Feb. 21, 2019, US 2019-0388654. [cited by applicant]
U.S. Appl. No. 16/297,348, filed Mar. 8, 2019, US 2020-0038576. [cited by applicant]
U.S. Appl. No. 16/299,524, filed Mar. 12, 2019, US 2019-0366070. [cited by applicant]
U.S. Appl. No. 16/353,492, filed Mar. 14, 2019, US 2020-0009406. [cited by applicant]
U.S. Appl. No. 16/377,663, filed Apr. 8, 2019, US 2019-0231962. [cited by applicant]
U.S. Appl. No. 16/513,030, filed Jul. 16, 2019, US 2020-0170637. [cited by applicant]
U.S. Appl. No. 16/544,083, filed Aug. 19, 2019, US 2020-0171277. [cited by applicant]
U.S. Appl. No. 16/547,042, filed Aug. 21, 2019, US 2020-0113587. [cited by applicant]
Bergeron, P., et al. (1999, First Published May 1, 1999 Research Article). “Percutaneous Stenting of the Internal Carotid Artery: The European Cast I Study. Journal of Endovascular Therapy.” 6(2), 155-159. https://doi.o… [cited by applicant]
PCT/US2021/045430, Aug. 10, 2021, WO 2022/035890. [cited by applicant]
U.S. Appl. No. 14/227,585, filed Mar. 27, 2014, US 2014-0296769. [cited by applicant]
U.S. Appl. No. 15/049,637, filed Feb. 22, 2016, US 2016-0242764. [cited by applicant]
U.S. Appl. No. 16/530,783, filed Aug. 2, 2019, US 2020-0054871. [cited by applicant]
U.S. Appl. No. 16/880,594, filed May 21, 2020, US 2020-0282127. [cited by applicant]
U.S. Appl. No. 16/894,474, filed Jun. 5, 2020, US 2020-0297912. [cited by applicant]
U.S. Appl. No. 16/906,457, filed Jun. 19, 2020, US 2020-0397472. [cited by applicant]
U.S. Appl. No. 16/939,396, filed Jul. 27, 2020, US 2020-0397446. [cited by applicant]
U.S. Appl. No. 16/951,767, filed Nov. 18, 2020, US 2021-0145453. [cited by applicant]
U.S. Appl. No. 16/999,634, filed Aug. 21, 2020, US 2020-0375728. [cited by applicant]
U.S. Appl. No. 16/999,640, filed Aug. 21, 2020, US 2020-0375729. [cited by applicant]
U.S. Appl. No. 17/000,004, filed Aug. 21, 2020, US 2020-0390438. [cited by applicant]
U.S. Appl. No. 17/074,299, filed Oct. 19, 2020, US 2021-0205571. [cited by applicant]
U.S. Appl. No. 17/092,635, filed Nov. 9, 2020, US 2021-0228847. [cited by applicant]
U.S. Appl. No. 17/108,711, filed Dec. 1, 2020, US 2021-0212679. [cited by applicant]
U.S. Appl. No. 17/149,450, filed Jan. 14, 2021, US 2021-0298929. [cited by applicant]
U.S. Appl. No. 17/179,746, filed Feb. 19, 2021, US 2021-0244522. [cited by applicant]
U.S. Appl. No. 17/193,962, filed Mar. 5, 2021, US 2021-0290257. [cited by applicant]
U.S. Appl. No. 17/206,665, filed Mar. 19, 2021, US 2021-0307945. [cited by applicant]
U.S. Appl. No. 17/220,718, filed Apr. 1, 2021, US 2021-0290213. [cited by applicant]
U.S. Appl. No. 17/237,911, filed Apr. 22, 2021, US 2021-0236790. [cited by applicant]
U.S. Appl. No. 17/307,359, filed May 4, 2021, US 2021-0322738. [cited by applicant]
U.S. Appl. No. 17/308,199, filed May 5, 2021, US 2021-0251634. [cited by applicant]
U.S. Appl. No. 17/345,502, filed Jun. 11, 2021, US 2021-0299343. [cited by applicant]
U.S. Appl. No. 17/345,544, filed Jun. 11, 2021, US 2021-0299425. [cited by applicant]
U.S. Appl. No. 17/398,969, filed Aug. 10, 2021, US 2022-0047267. [cited by applicant]
U.S. Appl. No. 17/406,822, filed Aug. 19, 2021, US 2022-0040502. [cited by applicant]
U.S. Appl. No. 17/470,213, filed Sep. 9, 2021, US 2022-0202552. [cited by applicant]
U.S. Appl. No. 17/555,127, filed Dec. 17, 2021, US 2022-0193321. [cited by applicant]
U.S. Appl. No. 17/684,745, filed Mar. 2, 2022, US 2023-0045964. [cited by applicant]
U.S. Appl. No. 17/749,423, filed May 20, 2022, US 2023-0001161. [cited by applicant]
U.S. Appl. No. 17/749,454, filed May 20, 2022, US 2023-0097442. [cited by applicant]
U.S. Appl. No. 17/773,200, filed Apr. 29, 2022, US 2022-0401111. [cited by applicant]
U.S. Appl. No. 17/773,206, filed Apr. 29, 2022, US 2022-0378565. [cited by applicant]
U.S. Appl. No. 17/899,279, filed Aug. 30, 2022, US 2023-0067426. [cited by applicant]
U.S. Appl. No. 17/951,727, filed Sep. 23, 2022, US 2023-0101242. [cited by applicant]
PCT/US2021/064188, Dec. 17, 2021, WO 2022/133302. [cited by applicant]
PCT/US2022/033588, Jun. 15, 2022, WO 2022/266195. [cited by applicant]
PCT/US2022/042074, Aug. 30, 2022, WO 2023/034325. [cited by applicant]
PCT/US2022/044533, Sep. 22, 2022, WO 2023/049343. [cited by applicant]